Plasma B-type natriuretic peptide levels in systolic heart failure
Richard W. Troughton(Canterbury Health Laboratories), Allan L. Klein(Cleveland Clinic), James D. Thomas(University College London), Mark Richards(National University Health System), Randall C. Starling(Cleveland Clinic), Timothy G. Yandle(The University of Melbourne), David Prior(St Vincent's Hospital Melbourne), Maureen G. Martin(Cleveland Clinic), Jeremy J. Pereira(Cleveland Clinic), James B. Young(Houston Methodist), Annitta Morehead(Cleveland Clinic), Annette M. Fogarty(Cleveland Clinic)
Cited by 272
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications
|Journal of the American Society of Echocardiography|2011|1.2k
Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography
|European Journal of Echocardiography|2011|1.1k
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
|European Journal of Heart Failure|2019|786
Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
|European Heart Journal|2011|764